{"schemaVersion":"peptidescanner-evidence-bundle/v1","canonicalUrl":"https://peptidescanner.com/evidence/v1/peptides/metreleptin.json","manifestUrl":"https://peptidescanner.com/evidence/v1/manifest.json","peptide":{"slug":"metreleptin","name":"Metreleptin","url":"https://peptidescanner.com/peptides/metreleptin/"},"addressing":"objects is keyed by objectPathId. A URL fragment #<objectPathId> on this file names one evidence object. Every version of a record is placed in the bundle of the record's current first peptide.","objectCount":43,"objects":{"clinicaltrials-gov-nct00025883-metreleptin-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct00025883-metreleptin:v1","objectPathId":"clinicaltrials-gov-nct00025883-metreleptin-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00025883-metreleptin/","json":"https://peptidescanner.com/evidence/v1/peptides/metreleptin.json#clinicaltrials-gov-nct00025883-metreleptin-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/metreleptin.md#clinicaltrials-gov-nct00025883-metreleptin-v1"},"story":{"slug":"clinicaltrials-gov-nct00025883-metreleptin","version":1,"domain":"Clinical trials","dateInSource":"2016-08-16","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["metreleptin"],"peptides":[{"slug":"metreleptin","url":"https://peptidescanner.com/peptides/metreleptin/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT00025883","sourceIds":["ctg-observation-nct00025883-2016-08-16-30ec99f1c298"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT00025883 at 2026-11-16T17:35:38.955Z. Its registry update date was 2016-08-16, and PeptideScanner's reviewed identity mapping was metreleptin.","sourceIds":["ctg-observation-nct00025883-2016-08-16-30ec99f1c298"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT00025883 at 2026-11-16T17:35:38.955Z. Its registry update date was 2016-08-16, and PeptideScanner's reviewed identity mapping was metreleptin.","sourceIds":["ctg-observation-nct00025883-2016-08-16-30ec99f1c298"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct00025883-2016-08-16-30ec99f1c298"]}],"sources":[{"id":"ctg-observation-nct00025883-2016-08-16-30ec99f1c298","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT00025883 · retained source version 2016-08-16:30ec99f1c2985c0c7e59827b2131cdafda0ec7ce9a327dcb4a1e070b80acc1bc","url":"https://clinicaltrials.gov/study/NCT00025883"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"9e7417f92eea6ab27061cb0a8a11c8ce1238f657943c714b2dbd2d424b9cae4b","tierARecordSha256":"461a8f4eed7ad730090e591709d73bfb09962680c0ab1457b1fccba26fef4e49"},"integrity":{"algorithm":"sha256","contentSha256":"aef5c96479a99508deb3d00a98c0313238051c21b3c1761f842a3ea948d62168"}},"clinicaltrials-gov-nct00085982-metreleptin-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct00085982-metreleptin:v1","objectPathId":"clinicaltrials-gov-nct00085982-metreleptin-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00085982-metreleptin/","json":"https://peptidescanner.com/evidence/v1/peptides/metreleptin.json#clinicaltrials-gov-nct00085982-metreleptin-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/metreleptin.md#clinicaltrials-gov-nct00085982-metreleptin-v1"},"story":{"slug":"clinicaltrials-gov-nct00085982-metreleptin","version":1,"domain":"Clinical trials","dateInSource":"2025-01-30","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["metreleptin"],"peptides":[{"slug":"metreleptin","url":"https://peptidescanner.com/peptides/metreleptin/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT00085982","sourceIds":["ctg-observation-nct00085982-2025-01-30-5e83e14fad93"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT00085982 at 2026-11-16T17:35:38.955Z. Its registry update date was 2025-01-30, and PeptideScanner's reviewed identity mapping was metreleptin.","sourceIds":["ctg-observation-nct00085982-2025-01-30-5e83e14fad93"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT00085982 at 2026-11-16T17:35:38.955Z. Its registry update date was 2025-01-30, and PeptideScanner's reviewed identity mapping was metreleptin.","sourceIds":["ctg-observation-nct00085982-2025-01-30-5e83e14fad93"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct00085982-2025-01-30-5e83e14fad93"]}],"sources":[{"id":"ctg-observation-nct00085982-2025-01-30-5e83e14fad93","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT00085982 · retained source version 2025-01-30:5e83e14fad935953cf05e9878067b7f78159bfec0d7b6f269c2fd533a552a413","url":"https://clinicaltrials.gov/study/NCT00085982"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"195a0d70f45eb2a0248d7d32725f12eb52f0d435baf572d120a39dd549eaeafa","tierARecordSha256":"6e5ebaa82df0df99a8607366185d88dd44fe6591158ec4331cae798fd3dd0a33"},"integrity":{"algorithm":"sha256","contentSha256":"d917184bc1433a112d549cbbf33923a54d4aa1cf3e85e448ae0c7fd8a3f6b7d2"}},"clinicaltrials-gov-nct00130117-metreleptin-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct00130117-metreleptin:v1","objectPathId":"clinicaltrials-gov-nct00130117-metreleptin-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00130117-metreleptin/","json":"https://peptidescanner.com/evidence/v1/peptides/metreleptin.json#clinicaltrials-gov-nct00130117-metreleptin-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/metreleptin.md#clinicaltrials-gov-nct00130117-metreleptin-v1"},"story":{"slug":"clinicaltrials-gov-nct00130117-metreleptin","version":1,"domain":"Clinical trials","dateInSource":"2017-05-17","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["metreleptin"],"peptides":[{"slug":"metreleptin","url":"https://peptidescanner.com/peptides/metreleptin/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT00130117","sourceIds":["ctg-observation-nct00130117-2017-05-17-2dd3c456e100"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT00130117 at 2026-11-16T17:35:38.955Z. Its registry update date was 2017-05-17, and PeptideScanner's reviewed identity mapping was metreleptin.","sourceIds":["ctg-observation-nct00130117-2017-05-17-2dd3c456e100"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT00130117 at 2026-11-16T17:35:38.955Z. Its registry update date was 2017-05-17, and PeptideScanner's reviewed identity mapping was metreleptin.","sourceIds":["ctg-observation-nct00130117-2017-05-17-2dd3c456e100"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct00130117-2017-05-17-2dd3c456e100"]}],"sources":[{"id":"ctg-observation-nct00130117-2017-05-17-2dd3c456e100","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT00130117 · retained source version 2017-05-17:2dd3c456e100b90828e6a2ecfc75d71b85bd512658d8a49e6538b9cdc98f65bd","url":"https://clinicaltrials.gov/study/NCT00130117"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"d3ab0476f02f6def402525f1e01ab95d6375b95c2844e89dcdad4257ffafd34a","tierARecordSha256":"faca0a5c9205407fd679540783220c4ecc92980e717f53dd426787ac3d412620"},"integrity":{"algorithm":"sha256","contentSha256":"e1f9a974709c602023e48c67d023a93b4699d4b44a2282e0fdc117cf10ee4e23"}},"clinicaltrials-gov-nct00140231-metreleptin-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct00140231-metreleptin:v1","objectPathId":"clinicaltrials-gov-nct00140231-metreleptin-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00140231-metreleptin/","json":"https://peptidescanner.com/evidence/v1/peptides/metreleptin.json#clinicaltrials-gov-nct00140231-metreleptin-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/metreleptin.md#clinicaltrials-gov-nct00140231-metreleptin-v1"},"story":{"slug":"clinicaltrials-gov-nct00140231-metreleptin","version":1,"domain":"Clinical trials","dateInSource":"2017-06-07","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["metreleptin"],"peptides":[{"slug":"metreleptin","url":"https://peptidescanner.com/peptides/metreleptin/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT00140231","sourceIds":["ctg-observation-nct00140231-2017-06-07-e20033ea23cd"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT00140231 at 2026-11-16T17:35:38.955Z. Its registry update date was 2017-06-07, and PeptideScanner's reviewed identity mapping was metreleptin.","sourceIds":["ctg-observation-nct00140231-2017-06-07-e20033ea23cd"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT00140231 at 2026-11-16T17:35:38.955Z. Its registry update date was 2017-06-07, and PeptideScanner's reviewed identity mapping was metreleptin.","sourceIds":["ctg-observation-nct00140231-2017-06-07-e20033ea23cd"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct00140231-2017-06-07-e20033ea23cd"]}],"sources":[{"id":"ctg-observation-nct00140231-2017-06-07-e20033ea23cd","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT00140231 · retained source version 2017-06-07:e20033ea23cd2653b0f6ecfceea51beb7078e33a833e37fa18ef7b5a39be08d1","url":"https://clinicaltrials.gov/study/NCT00140231"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"d64629d2e9fed8a1e8280c81796fd7ad867e7fe62acccfc6448ef2204d221f2c","tierARecordSha256":"65f87343e752f3214542b3ad88fe86342502a4c6bb215ee4bc5fbf297774a6e2"},"integrity":{"algorithm":"sha256","contentSha256":"d347930aba043cd971841f377877fdb06c49a1b090016555d776207b187a01bf"}},"clinicaltrials-gov-nct00392925-metreleptin-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct00392925-metreleptin:v1","objectPathId":"clinicaltrials-gov-nct00392925-metreleptin-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00392925-metreleptin/","json":"https://peptidescanner.com/evidence/v1/peptides/metreleptin.json#clinicaltrials-gov-nct00392925-metreleptin-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/metreleptin.md#clinicaltrials-gov-nct00392925-metreleptin-v1"},"story":{"slug":"clinicaltrials-gov-nct00392925-metreleptin","version":1,"domain":"Clinical trials","dateInSource":"2015-04-14","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["metreleptin"],"peptides":[{"slug":"metreleptin","url":"https://peptidescanner.com/peptides/metreleptin/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT00392925","sourceIds":["ctg-observation-nct00392925-2015-04-14-d632c3d667a5"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT00392925 at 2026-11-16T17:35:38.955Z. Its registry update date was 2015-04-14, and PeptideScanner's reviewed identity mapping was metreleptin.","sourceIds":["ctg-observation-nct00392925-2015-04-14-d632c3d667a5"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT00392925 at 2026-11-16T17:35:38.955Z. Its registry update date was 2015-04-14, and PeptideScanner's reviewed identity mapping was metreleptin.","sourceIds":["ctg-observation-nct00392925-2015-04-14-d632c3d667a5"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct00392925-2015-04-14-d632c3d667a5"]}],"sources":[{"id":"ctg-observation-nct00392925-2015-04-14-d632c3d667a5","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT00392925 · retained source version 2015-04-14:d632c3d667a558ca6a999d77210bbef7640a6d52318266abd22cf55f97d00a92","url":"https://clinicaltrials.gov/study/NCT00392925"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"08ce283fc788aadf98afaa475bd91ba7a131c3b6dee8d464f8ba79d598968648","tierARecordSha256":"9ba8d76c54130275ebda1c99528fd1365d18e5a5d7075fd5ecbec28b0f8326c9"},"integrity":{"algorithm":"sha256","contentSha256":"bc252e6f5d3217e622eb3e7d89e7decbdecedceb8582ae8369bfc7c85f10bca1"}},"clinicaltrials-gov-nct00461552-metreleptin-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct00461552-metreleptin:v1","objectPathId":"clinicaltrials-gov-nct00461552-metreleptin-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00461552-metreleptin/","json":"https://peptidescanner.com/evidence/v1/peptides/metreleptin.json#clinicaltrials-gov-nct00461552-metreleptin-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/metreleptin.md#clinicaltrials-gov-nct00461552-metreleptin-v1"},"story":{"slug":"clinicaltrials-gov-nct00461552-metreleptin","version":1,"domain":"Clinical trials","dateInSource":"2019-05-09","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["metreleptin"],"peptides":[{"slug":"metreleptin","url":"https://peptidescanner.com/peptides/metreleptin/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT00461552","sourceIds":["ctg-observation-nct00461552-2019-05-09-f34e4799ef58"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT00461552 at 2026-11-16T17:35:38.955Z. Its registry update date was 2019-05-09, and PeptideScanner's reviewed identity mapping was metreleptin.","sourceIds":["ctg-observation-nct00461552-2019-05-09-f34e4799ef58"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT00461552 at 2026-11-16T17:35:38.955Z. Its registry update date was 2019-05-09, and PeptideScanner's reviewed identity mapping was metreleptin.","sourceIds":["ctg-observation-nct00461552-2019-05-09-f34e4799ef58"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct00461552-2019-05-09-f34e4799ef58"]}],"sources":[{"id":"ctg-observation-nct00461552-2019-05-09-f34e4799ef58","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT00461552 · retained source version 2019-05-09:f34e4799ef5876152b56a1b6d5e923e2a2a076d70f4cac6083f8d585146b51f5","url":"https://clinicaltrials.gov/study/NCT00461552"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"c7c7b32bb1c6e36667e67ff10fca719c02a17b1b050edbc385a2ca7c037ecac2","tierARecordSha256":"980fd9348078c84f6a70a0047b3d288938a86b3d6390e06570add29f2a1224b2"},"integrity":{"algorithm":"sha256","contentSha256":"49eb7f1de68c42e8a83a57b31485d75ce74859e20f08d279512ee5cf133d48cb"}},"clinicaltrials-gov-nct00596934-metreleptin-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct00596934-metreleptin:v1","objectPathId":"clinicaltrials-gov-nct00596934-metreleptin-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00596934-metreleptin/","json":"https://peptidescanner.com/evidence/v1/peptides/metreleptin.json#clinicaltrials-gov-nct00596934-metreleptin-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/metreleptin.md#clinicaltrials-gov-nct00596934-metreleptin-v1"},"story":{"slug":"clinicaltrials-gov-nct00596934-metreleptin","version":1,"domain":"Clinical trials","dateInSource":"2017-11-24","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["metreleptin"],"peptides":[{"slug":"metreleptin","url":"https://peptidescanner.com/peptides/metreleptin/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT00596934","sourceIds":["ctg-observation-nct00596934-2017-11-24-630304b260f5"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT00596934 at 2026-11-16T17:35:38.955Z. Its registry update date was 2017-11-24, and PeptideScanner's reviewed identity mapping was metreleptin.","sourceIds":["ctg-observation-nct00596934-2017-11-24-630304b260f5"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT00596934 at 2026-11-16T17:35:38.955Z. Its registry update date was 2017-11-24, and PeptideScanner's reviewed identity mapping was metreleptin.","sourceIds":["ctg-observation-nct00596934-2017-11-24-630304b260f5"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct00596934-2017-11-24-630304b260f5"]}],"sources":[{"id":"ctg-observation-nct00596934-2017-11-24-630304b260f5","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT00596934 · retained source version 2017-11-24:630304b260f5a0c7fdcd9d9f4f49f5c6465786cfe4aa3e371c382bbe7d151858","url":"https://clinicaltrials.gov/study/NCT00596934"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"8d44768974599777a495e52d6c3fc3fd604e4e90e45faacaff5eeae782536ec9","tierARecordSha256":"0be3be4d2039ea1d2950983337980c98574c9d63efd5383b6b71e12ca9475b14"},"integrity":{"algorithm":"sha256","contentSha256":"1081b2c460cb760e10241f9ee01ee5e806ce4e9893ce8b70eb9b04135bfaed75"}},"clinicaltrials-gov-nct00657605-metreleptin-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct00657605-metreleptin:v1","objectPathId":"clinicaltrials-gov-nct00657605-metreleptin-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00657605-metreleptin/","json":"https://peptidescanner.com/evidence/v1/peptides/metreleptin.json#clinicaltrials-gov-nct00657605-metreleptin-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/metreleptin.md#clinicaltrials-gov-nct00657605-metreleptin-v1"},"story":{"slug":"clinicaltrials-gov-nct00657605-metreleptin","version":1,"domain":"Clinical trials","dateInSource":"2020-02-13","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["metreleptin"],"peptides":[{"slug":"metreleptin","url":"https://peptidescanner.com/peptides/metreleptin/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT00657605","sourceIds":["ctg-observation-nct00657605-2020-02-13-16e7cec66cee"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT00657605 at 2026-11-16T17:35:38.955Z. Its registry update date was 2020-02-13, and PeptideScanner's reviewed identity mapping was metreleptin.","sourceIds":["ctg-observation-nct00657605-2020-02-13-16e7cec66cee"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT00657605 at 2026-11-16T17:35:38.955Z. Its registry update date was 2020-02-13, and PeptideScanner's reviewed identity mapping was metreleptin.","sourceIds":["ctg-observation-nct00657605-2020-02-13-16e7cec66cee"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct00657605-2020-02-13-16e7cec66cee"]}],"sources":[{"id":"ctg-observation-nct00657605-2020-02-13-16e7cec66cee","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT00657605 · retained source version 2020-02-13:16e7cec66cee86aa9008d0ee3a87fff2fc8d1c8cfe109b584aca51adc6628721","url":"https://clinicaltrials.gov/study/NCT00657605"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"6a0bde753b577087eafa6c445f0ba21dff35336afb566768a3d6b24b274d4411","tierARecordSha256":"005bab8190f8e220dc6315a4ecc675226d10d13f3eed2c58912b2b4782d727ba"},"integrity":{"algorithm":"sha256","contentSha256":"6668f35d37ebf4c7a49920344d60bf4928690dbea37ab3935d6acdd8795b6a89"}},"clinicaltrials-gov-nct00659828-metreleptin-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct00659828-metreleptin:v1","objectPathId":"clinicaltrials-gov-nct00659828-metreleptin-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00659828-metreleptin/","json":"https://peptidescanner.com/evidence/v1/peptides/metreleptin.json#clinicaltrials-gov-nct00659828-metreleptin-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/metreleptin.md#clinicaltrials-gov-nct00659828-metreleptin-v1"},"story":{"slug":"clinicaltrials-gov-nct00659828-metreleptin","version":1,"domain":"Clinical trials","dateInSource":"2020-02-13","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["metreleptin"],"peptides":[{"slug":"metreleptin","url":"https://peptidescanner.com/peptides/metreleptin/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT00659828","sourceIds":["ctg-observation-nct00659828-2020-02-13-b7a97bd48066"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT00659828 at 2026-11-16T17:35:38.955Z. Its registry update date was 2020-02-13, and PeptideScanner's reviewed identity mapping was metreleptin.","sourceIds":["ctg-observation-nct00659828-2020-02-13-b7a97bd48066"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT00659828 at 2026-11-16T17:35:38.955Z. Its registry update date was 2020-02-13, and PeptideScanner's reviewed identity mapping was metreleptin.","sourceIds":["ctg-observation-nct00659828-2020-02-13-b7a97bd48066"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct00659828-2020-02-13-b7a97bd48066"]}],"sources":[{"id":"ctg-observation-nct00659828-2020-02-13-b7a97bd48066","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT00659828 · retained source version 2020-02-13:b7a97bd4806619e9d3dcac2011d0dff6c011bf2ad8d6761dfac2b9609d722dd0","url":"https://clinicaltrials.gov/study/NCT00659828"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"0fd9bec268e0197d4a207f9998656e653687df5faac229ec2831809be353609a","tierARecordSha256":"d8c959140029a14b2b84b900e27c4152f9a9ebe8c877f9a10b3839a32baafabf"},"integrity":{"algorithm":"sha256","contentSha256":"7f59ec1c6d61e5ddb6a431b383332975ba82e1aeda8d92e35c84d0c7fd601662"}},"clinicaltrials-gov-nct00673387-metreleptin-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct00673387-metreleptin:v1","objectPathId":"clinicaltrials-gov-nct00673387-metreleptin-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00673387-metreleptin/","json":"https://peptidescanner.com/evidence/v1/peptides/metreleptin.json#clinicaltrials-gov-nct00673387-metreleptin-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/metreleptin.md#clinicaltrials-gov-nct00673387-metreleptin-v1"},"story":{"slug":"clinicaltrials-gov-nct00673387-metreleptin","version":1,"domain":"Clinical trials","dateInSource":"2015-04-15","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["metreleptin"],"peptides":[{"slug":"metreleptin","url":"https://peptidescanner.com/peptides/metreleptin/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT00673387","sourceIds":["ctg-observation-nct00673387-2015-04-15-f63d30b51336"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT00673387 at 2026-11-16T17:35:38.955Z. Its registry update date was 2015-04-15, and PeptideScanner's reviewed identity mapping was metreleptin.","sourceIds":["ctg-observation-nct00673387-2015-04-15-f63d30b51336"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT00673387 at 2026-11-16T17:35:38.955Z. Its registry update date was 2015-04-15, and PeptideScanner's reviewed identity mapping was metreleptin.","sourceIds":["ctg-observation-nct00673387-2015-04-15-f63d30b51336"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct00673387-2015-04-15-f63d30b51336"]}],"sources":[{"id":"ctg-observation-nct00673387-2015-04-15-f63d30b51336","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT00673387 · retained source version 2015-04-15:f63d30b5133670a7deb3d8244dafa0521caa62503abfbb258db5aa85ea3eb168","url":"https://clinicaltrials.gov/study/NCT00673387"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"a61e6072970a8b1c45fd3bd7025b9e9d2b11bd43bc39dc893b76dda3215f18bb","tierARecordSha256":"c0ef596d4e15f8e405cd810b982990ffd887943fe2fcbb25af9a08b4e02b2805"},"integrity":{"algorithm":"sha256","contentSha256":"ba446e8de80e28f0479375cb2d185113f1c7f9efecd058930fa7582a240731e1"}},"clinicaltrials-gov-nct00710814-metreleptin-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct00710814-metreleptin:v1","objectPathId":"clinicaltrials-gov-nct00710814-metreleptin-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00710814-metreleptin/","json":"https://peptidescanner.com/evidence/v1/peptides/metreleptin.json#clinicaltrials-gov-nct00710814-metreleptin-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/metreleptin.md#clinicaltrials-gov-nct00710814-metreleptin-v1"},"story":{"slug":"clinicaltrials-gov-nct00710814-metreleptin","version":1,"domain":"Clinical trials","dateInSource":"2015-11-16","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["metreleptin"],"peptides":[{"slug":"metreleptin","url":"https://peptidescanner.com/peptides/metreleptin/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT00710814","sourceIds":["ctg-observation-nct00710814-2015-11-16-b95d092ec7dd"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT00710814 at 2026-11-16T17:35:38.955Z. Its registry update date was 2015-11-16, and PeptideScanner's reviewed identity mapping was metreleptin.","sourceIds":["ctg-observation-nct00710814-2015-11-16-b95d092ec7dd"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT00710814 at 2026-11-16T17:35:38.955Z. Its registry update date was 2015-11-16, and PeptideScanner's reviewed identity mapping was metreleptin.","sourceIds":["ctg-observation-nct00710814-2015-11-16-b95d092ec7dd"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct00710814-2015-11-16-b95d092ec7dd"]}],"sources":[{"id":"ctg-observation-nct00710814-2015-11-16-b95d092ec7dd","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT00710814 · retained source version 2015-11-16:b95d092ec7ddfac5418f1a0abae781712da62d1de3c3f2df1467842f22b49642","url":"https://clinicaltrials.gov/study/NCT00710814"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"1f4e3374bb70925deb8cfe71c5d3fca36b1575e92a536691c6652e661f4c7221","tierARecordSha256":"eb791254bee3a1747ea4f9d24ad58f0621ac54f950b99b431cecf7c6bc40539f"},"integrity":{"algorithm":"sha256","contentSha256":"ed3496c7d0ccc5f01e440c68df3628b73da5f8a6805277ef721a146a444bac2c"}},"clinicaltrials-gov-nct01155180-metreleptin-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct01155180-metreleptin:v1","objectPathId":"clinicaltrials-gov-nct01155180-metreleptin-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct01155180-metreleptin/","json":"https://peptidescanner.com/evidence/v1/peptides/metreleptin.json#clinicaltrials-gov-nct01155180-metreleptin-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/metreleptin.md#clinicaltrials-gov-nct01155180-metreleptin-v1"},"story":{"slug":"clinicaltrials-gov-nct01155180-metreleptin","version":1,"domain":"Clinical trials","dateInSource":"2017-04-07","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["metreleptin"],"peptides":[{"slug":"metreleptin","url":"https://peptidescanner.com/peptides/metreleptin/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT01155180","sourceIds":["ctg-observation-nct01155180-2017-04-07-6a316433120f"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT01155180 at 2026-11-16T17:35:38.955Z. Its registry update date was 2017-04-07, and PeptideScanner's reviewed identity mapping was metreleptin.","sourceIds":["ctg-observation-nct01155180-2017-04-07-6a316433120f"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT01155180 at 2026-11-16T17:35:38.955Z. Its registry update date was 2017-04-07, and PeptideScanner's reviewed identity mapping was metreleptin.","sourceIds":["ctg-observation-nct01155180-2017-04-07-6a316433120f"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct01155180-2017-04-07-6a316433120f"]}],"sources":[{"id":"ctg-observation-nct01155180-2017-04-07-6a316433120f","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT01155180 · retained source version 2017-04-07:6a316433120f369a491798124cf1c937dced573423d0d6be0b1935196f2a702c","url":"https://clinicaltrials.gov/study/NCT01155180"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"267343a4b9fb7c96b6723e84958e97411f75e47c367149a1ba9f24a7c9e624bf","tierARecordSha256":"2088cb203610f50183c749808da6b8eb7e5b1a77e3e344556ad6e52e492615eb"},"integrity":{"algorithm":"sha256","contentSha256":"d43fd503534b3f81eb11b9f6c69973d2323d28c8369d7bd4582d37e0d1851b08"}},"clinicaltrials-gov-nct01511016-metreleptin-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct01511016-metreleptin:v1","objectPathId":"clinicaltrials-gov-nct01511016-metreleptin-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct01511016-metreleptin/","json":"https://peptidescanner.com/evidence/v1/peptides/metreleptin.json#clinicaltrials-gov-nct01511016-metreleptin-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/metreleptin.md#clinicaltrials-gov-nct01511016-metreleptin-v1"},"story":{"slug":"clinicaltrials-gov-nct01511016-metreleptin","version":1,"domain":"Clinical trials","dateInSource":"2016-01-27","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["metreleptin"],"peptides":[{"slug":"metreleptin","url":"https://peptidescanner.com/peptides/metreleptin/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT01511016","sourceIds":["ctg-observation-nct01511016-2016-01-27-e7a0a06ac357"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT01511016 at 2026-11-16T17:35:38.955Z. Its registry update date was 2016-01-27, and PeptideScanner's reviewed identity mapping was metreleptin.","sourceIds":["ctg-observation-nct01511016-2016-01-27-e7a0a06ac357"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT01511016 at 2026-11-16T17:35:38.955Z. Its registry update date was 2016-01-27, and PeptideScanner's reviewed identity mapping was metreleptin.","sourceIds":["ctg-observation-nct01511016-2016-01-27-e7a0a06ac357"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct01511016-2016-01-27-e7a0a06ac357"]}],"sources":[{"id":"ctg-observation-nct01511016-2016-01-27-e7a0a06ac357","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT01511016 · retained source version 2016-01-27:e7a0a06ac357bb7e995ea6ecbf589c5d7a9a50a0d58f0abb97968e62437ea36f","url":"https://clinicaltrials.gov/study/NCT01511016"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"5b529fd4195b59b2b0b3afca3e63674ca33bd4745f0c991ec2f919724f116280","tierARecordSha256":"bc0f11efff2247f3276e00783c31b1a26fc1a56def2441aff16617d8ac91a1a4"},"integrity":{"algorithm":"sha256","contentSha256":"d4634829bab464f0fea0ea74534eb9728bb865b6c26d7e565fc730b6f4b54485"}},"clinicaltrials-gov-nct01679197-metreleptin-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct01679197-metreleptin:v1","objectPathId":"clinicaltrials-gov-nct01679197-metreleptin-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct01679197-metreleptin/","json":"https://peptidescanner.com/evidence/v1/peptides/metreleptin.json#clinicaltrials-gov-nct01679197-metreleptin-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/metreleptin.md#clinicaltrials-gov-nct01679197-metreleptin-v1"},"story":{"slug":"clinicaltrials-gov-nct01679197-metreleptin","version":1,"domain":"Clinical trials","dateInSource":"2017-06-14","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["metreleptin"],"peptides":[{"slug":"metreleptin","url":"https://peptidescanner.com/peptides/metreleptin/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT01679197","sourceIds":["ctg-observation-nct01679197-2017-06-14-707f672e4db3"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT01679197 at 2026-11-16T17:35:38.955Z. Its registry update date was 2017-06-14, and PeptideScanner's reviewed identity mapping was metreleptin.","sourceIds":["ctg-observation-nct01679197-2017-06-14-707f672e4db3"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT01679197 at 2026-11-16T17:35:38.955Z. Its registry update date was 2017-06-14, and PeptideScanner's reviewed identity mapping was metreleptin.","sourceIds":["ctg-observation-nct01679197-2017-06-14-707f672e4db3"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct01679197-2017-06-14-707f672e4db3"]}],"sources":[{"id":"ctg-observation-nct01679197-2017-06-14-707f672e4db3","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT01679197 · retained source version 2017-06-14:707f672e4db38466c27f0ededfed7eafbb8b8834345cbc27dfe6e30efab05930","url":"https://clinicaltrials.gov/study/NCT01679197"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"912c25c60eb03415687ded74a2ca9f13a267a031c6e12969c8b9d769c66a539f","tierARecordSha256":"e7056454dcc1ba49c5778fe0b723b77439e92d12776d159ca4eb27babf48555e"},"integrity":{"algorithm":"sha256","contentSha256":"35e28cd80805c7e17272186ec94c98c33ae0a54b44ec0351cf517dd0c3dc50fe"}},"clinicaltrials-gov-nct01778556-metreleptin-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct01778556-metreleptin:v1","objectPathId":"clinicaltrials-gov-nct01778556-metreleptin-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct01778556-metreleptin/","json":"https://peptidescanner.com/evidence/v1/peptides/metreleptin.json#clinicaltrials-gov-nct01778556-metreleptin-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/metreleptin.md#clinicaltrials-gov-nct01778556-metreleptin-v1"},"story":{"slug":"clinicaltrials-gov-nct01778556-metreleptin","version":1,"domain":"Clinical trials","dateInSource":"2019-11-13","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["metreleptin"],"peptides":[{"slug":"metreleptin","url":"https://peptidescanner.com/peptides/metreleptin/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT01778556","sourceIds":["ctg-observation-nct01778556-2019-11-13-e13e4224f30c"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT01778556 at 2026-11-16T17:35:38.955Z. Its registry update date was 2019-11-13, and PeptideScanner's reviewed identity mapping was metreleptin.","sourceIds":["ctg-observation-nct01778556-2019-11-13-e13e4224f30c"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT01778556 at 2026-11-16T17:35:38.955Z. Its registry update date was 2019-11-13, and PeptideScanner's reviewed identity mapping was metreleptin.","sourceIds":["ctg-observation-nct01778556-2019-11-13-e13e4224f30c"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct01778556-2019-11-13-e13e4224f30c"]}],"sources":[{"id":"ctg-observation-nct01778556-2019-11-13-e13e4224f30c","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT01778556 · retained source version 2019-11-13:e13e4224f30c708a03a18c91978613865dd84e71816e30793dbb81888d299789","url":"https://clinicaltrials.gov/study/NCT01778556"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"8f8911b067d6fe824818e667722669debcdc70bee8c145b77ad8fefe31a6826a","tierARecordSha256":"e0c9add9c3b5103d6132768b15de5d3f2c3bf4ee56f14cf3beea1bd0f671e55c"},"integrity":{"algorithm":"sha256","contentSha256":"9635b0c7274a447b251c62b20a1d29aaa6413a73020199c9f6b8ad61b4a5a416"}},"clinicaltrials-gov-nct02262806-metreleptin-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct02262806-metreleptin:v1","objectPathId":"clinicaltrials-gov-nct02262806-metreleptin-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct02262806-metreleptin/","json":"https://peptidescanner.com/evidence/v1/peptides/metreleptin.json#clinicaltrials-gov-nct02262806-metreleptin-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/metreleptin.md#clinicaltrials-gov-nct02262806-metreleptin-v1"},"story":{"slug":"clinicaltrials-gov-nct02262806-metreleptin","version":1,"domain":"Clinical trials","dateInSource":"2026-11-09","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["metreleptin"],"peptides":[{"slug":"metreleptin","url":"https://peptidescanner.com/peptides/metreleptin/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT02262806","sourceIds":["ctg-observation-nct02262806-2026-11-09-4afeebdf1d95"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT02262806 at 2026-11-16T17:35:38.955Z. Its registry update date was 2026-11-09, and PeptideScanner's reviewed identity mapping was metreleptin.","sourceIds":["ctg-observation-nct02262806-2026-11-09-4afeebdf1d95"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT02262806 at 2026-11-16T17:35:38.955Z. Its registry update date was 2026-11-09, and PeptideScanner's reviewed identity mapping was metreleptin.","sourceIds":["ctg-observation-nct02262806-2026-11-09-4afeebdf1d95"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct02262806-2026-11-09-4afeebdf1d95"]}],"sources":[{"id":"ctg-observation-nct02262806-2026-11-09-4afeebdf1d95","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT02262806 · retained source version 2026-11-09:4afeebdf1d959d401291774cfe7fed2aec879d2b2c004c8f7c7b95a77d78b53d","url":"https://clinicaltrials.gov/study/NCT02262806"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"0affdc6627d3b7c7a11344c8e4b36850e789d83c63623ccb3f64b366042fe1e4","tierARecordSha256":"8d0e84e4ed56bdfecb15ef923c11a6db6183ff8385fcd44cb7e3e42f12d61a6a"},"integrity":{"algorithm":"sha256","contentSha256":"eef2844ad6c928e80b4adfc049da1316e2acd6817c2bdf5dad9ad015aad28157"}},"clinicaltrials-gov-nct02262832-metreleptin-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct02262832-metreleptin:v1","objectPathId":"clinicaltrials-gov-nct02262832-metreleptin-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct02262832-metreleptin/","json":"https://peptidescanner.com/evidence/v1/peptides/metreleptin.json#clinicaltrials-gov-nct02262832-metreleptin-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/metreleptin.md#clinicaltrials-gov-nct02262832-metreleptin-v1"},"story":{"slug":"clinicaltrials-gov-nct02262832-metreleptin","version":1,"domain":"Clinical trials","dateInSource":"2026-10-27","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["metreleptin"],"peptides":[{"slug":"metreleptin","url":"https://peptidescanner.com/peptides/metreleptin/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT02262832","sourceIds":["ctg-observation-nct02262832-2026-10-27-509810967c2f"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT02262832 at 2026-11-16T17:35:38.955Z. Its registry update date was 2026-10-27, and PeptideScanner's reviewed identity mapping was metreleptin.","sourceIds":["ctg-observation-nct02262832-2026-10-27-509810967c2f"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT02262832 at 2026-11-16T17:35:38.955Z. Its registry update date was 2026-10-27, and PeptideScanner's reviewed identity mapping was metreleptin.","sourceIds":["ctg-observation-nct02262832-2026-10-27-509810967c2f"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct02262832-2026-10-27-509810967c2f"]}],"sources":[{"id":"ctg-observation-nct02262832-2026-10-27-509810967c2f","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT02262832 · retained source version 2026-10-27:509810967c2f0a755a6f87b1cef66ef1ccc6d6190435151ea699edc98280879a","url":"https://clinicaltrials.gov/study/NCT02262832"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"1ea7418917812b7c958c2c1c7037f3749e345a2709ac6fe14a00d9bd93bb2c1f","tierARecordSha256":"b0af6f4aac952c0f069ff2caea3c81936d07cb3a4fb2570fb92ed65eb9e7e3f1"},"integrity":{"algorithm":"sha256","contentSha256":"adf1dea5569b718edaa5aaa7db16ee27e4ea42fed05a877794f92a22e5518816"}},"clinicaltrials-gov-nct02325674-metreleptin-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct02325674-metreleptin:v1","objectPathId":"clinicaltrials-gov-nct02325674-metreleptin-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct02325674-metreleptin/","json":"https://peptidescanner.com/evidence/v1/peptides/metreleptin.json#clinicaltrials-gov-nct02325674-metreleptin-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/metreleptin.md#clinicaltrials-gov-nct02325674-metreleptin-v1"},"story":{"slug":"clinicaltrials-gov-nct02325674-metreleptin","version":1,"domain":"Clinical trials","dateInSource":"2026-07-16","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["metreleptin"],"peptides":[{"slug":"metreleptin","url":"https://peptidescanner.com/peptides/metreleptin/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT02325674","sourceIds":["ctg-observation-nct02325674-2026-07-16-6d7440a41180"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT02325674 at 2026-11-16T17:35:38.955Z. Its registry update date was 2026-07-16, and PeptideScanner's reviewed identity mapping was metreleptin.","sourceIds":["ctg-observation-nct02325674-2026-07-16-6d7440a41180"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT02325674 at 2026-11-16T17:35:38.955Z. Its registry update date was 2026-07-16, and PeptideScanner's reviewed identity mapping was metreleptin.","sourceIds":["ctg-observation-nct02325674-2026-07-16-6d7440a41180"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct02325674-2026-07-16-6d7440a41180"]}],"sources":[{"id":"ctg-observation-nct02325674-2026-07-16-6d7440a41180","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT02325674 · retained source version 2026-07-16:6d7440a41180343499c88bfe48ec6419d3daec350f056a3844038081d9634f08","url":"https://clinicaltrials.gov/study/NCT02325674"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"2a3b97d7cd2cdcda403e3f40ad3cbffcd652871f89b478d66b7043f4e077c622","tierARecordSha256":"8d5c6a39a7ea7af7e767ce1bbe3d58cf5d61bc3c45f11af4755fb0ce9c3dd80e"},"integrity":{"algorithm":"sha256","contentSha256":"0ba8eac8600d96fac0cfcc57b69c06d06344340e3d730cb0e39d3eb91975f4a3"}},"clinicaltrials-gov-nct02654977-metreleptin-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct02654977-metreleptin:v1","objectPathId":"clinicaltrials-gov-nct02654977-metreleptin-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct02654977-metreleptin/","json":"https://peptidescanner.com/evidence/v1/peptides/metreleptin.json#clinicaltrials-gov-nct02654977-metreleptin-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/metreleptin.md#clinicaltrials-gov-nct02654977-metreleptin-v1"},"story":{"slug":"clinicaltrials-gov-nct02654977-metreleptin","version":1,"domain":"Clinical trials","dateInSource":"2020-11-24","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["metreleptin"],"peptides":[{"slug":"metreleptin","url":"https://peptidescanner.com/peptides/metreleptin/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT02654977","sourceIds":["ctg-observation-nct02654977-2020-11-24-d105bfa34682"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT02654977 at 2026-11-16T17:35:38.955Z. Its registry update date was 2020-11-24, and PeptideScanner's reviewed identity mapping was metreleptin.","sourceIds":["ctg-observation-nct02654977-2020-11-24-d105bfa34682"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT02654977 at 2026-11-16T17:35:38.955Z. Its registry update date was 2020-11-24, and PeptideScanner's reviewed identity mapping was metreleptin.","sourceIds":["ctg-observation-nct02654977-2020-11-24-d105bfa34682"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct02654977-2020-11-24-d105bfa34682"]}],"sources":[{"id":"ctg-observation-nct02654977-2020-11-24-d105bfa34682","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT02654977 · retained source version 2020-11-24:d105bfa34682036f00af949438cd17751fe6ef6b6e37a106d5680f31d9aefdbe","url":"https://clinicaltrials.gov/study/NCT02654977"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"75abbba69e26d477e69d692ada7167e09cccb44f5e0c440f8d89dcdf6800adc1","tierARecordSha256":"8aea8b41959f4e80594972d631a2348bf61ecfbf81d20e17d520dbe674f30f77"},"integrity":{"algorithm":"sha256","contentSha256":"20f75a334bc26f7f0fc89bf0468d7dd090e4fa6bf6d1baa3f62bec2486a5cc3a"}},"clinicaltrials-gov-nct04026178-metreleptin-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct04026178-metreleptin:v1","objectPathId":"clinicaltrials-gov-nct04026178-metreleptin-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct04026178-metreleptin/","json":"https://peptidescanner.com/evidence/v1/peptides/metreleptin.json#clinicaltrials-gov-nct04026178-metreleptin-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/metreleptin.md#clinicaltrials-gov-nct04026178-metreleptin-v1"},"story":{"slug":"clinicaltrials-gov-nct04026178-metreleptin","version":1,"domain":"Clinical trials","dateInSource":"2025-11-26","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["metreleptin"],"peptides":[{"slug":"metreleptin","url":"https://peptidescanner.com/peptides/metreleptin/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT04026178","sourceIds":["ctg-observation-nct04026178-2025-11-26-dc2eec706ede"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT04026178 at 2026-11-16T17:35:38.955Z. Its registry update date was 2025-11-26, and PeptideScanner's reviewed identity mapping was metreleptin.","sourceIds":["ctg-observation-nct04026178-2025-11-26-dc2eec706ede"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT04026178 at 2026-11-16T17:35:38.955Z. Its registry update date was 2025-11-26, and PeptideScanner's reviewed identity mapping was metreleptin.","sourceIds":["ctg-observation-nct04026178-2025-11-26-dc2eec706ede"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct04026178-2025-11-26-dc2eec706ede"]}],"sources":[{"id":"ctg-observation-nct04026178-2025-11-26-dc2eec706ede","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT04026178 · retained source version 2025-11-26:dc2eec706edec09fc2eef8e11e604a0b3af5539d624b12785d156ff34885382c","url":"https://clinicaltrials.gov/study/NCT04026178"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"4015824db942f12d8256d6b437f8e8c119893f363b769351a2476106b54ceaeb","tierARecordSha256":"74dee36c19bb6dea9b3a2a09db327c594060af98f4228e8a43de78d576a98328"},"integrity":{"algorithm":"sha256","contentSha256":"f36251c4619321f7ea5bbe8f0c7f855e209bbb9b4c796f9aedfc4821e92d0b44"}},"clinicaltrials-gov-nct05164341-metreleptin-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct05164341-metreleptin:v1","objectPathId":"clinicaltrials-gov-nct05164341-metreleptin-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct05164341-metreleptin/","json":"https://peptidescanner.com/evidence/v1/peptides/metreleptin.json#clinicaltrials-gov-nct05164341-metreleptin-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/metreleptin.md#clinicaltrials-gov-nct05164341-metreleptin-v1"},"story":{"slug":"clinicaltrials-gov-nct05164341-metreleptin","version":1,"domain":"Clinical trials","dateInSource":"2026-11-09","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["metreleptin"],"peptides":[{"slug":"metreleptin","url":"https://peptidescanner.com/peptides/metreleptin/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT05164341","sourceIds":["ctg-observation-nct05164341-2026-11-09-71bbae988874"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT05164341 at 2026-11-16T17:35:38.955Z. Its registry update date was 2026-11-09, and PeptideScanner's reviewed identity mapping was metreleptin.","sourceIds":["ctg-observation-nct05164341-2026-11-09-71bbae988874"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT05164341 at 2026-11-16T17:35:38.955Z. Its registry update date was 2026-11-09, and PeptideScanner's reviewed identity mapping was metreleptin.","sourceIds":["ctg-observation-nct05164341-2026-11-09-71bbae988874"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct05164341-2026-11-09-71bbae988874"]}],"sources":[{"id":"ctg-observation-nct05164341-2026-11-09-71bbae988874","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT05164341 · retained source version 2026-11-09:71bbae9888741c75e3b59073f27c20864de7a3f0bb3809c6ccfa74fccfc81fde","url":"https://clinicaltrials.gov/study/NCT05164341"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"0ca1568470071be490fa9411a03929e17042fc5c93ccccb78ca964077763c532","tierARecordSha256":"0061bd1170c745fbc98d34bbf4441675b381ed0b20c7b9eb28da5045687bf622"},"integrity":{"algorithm":"sha256","contentSha256":"147977ce8c1385eea8312338538bb1641e4d193826cb4ba9b18674ada8e9c012"}},"clinicaltrials-gov-nct05351164-metreleptin-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct05351164-metreleptin:v1","objectPathId":"clinicaltrials-gov-nct05351164-metreleptin-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct05351164-metreleptin/","json":"https://peptidescanner.com/evidence/v1/peptides/metreleptin.json#clinicaltrials-gov-nct05351164-metreleptin-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/metreleptin.md#clinicaltrials-gov-nct05351164-metreleptin-v1"},"story":{"slug":"clinicaltrials-gov-nct05351164-metreleptin","version":1,"domain":"Clinical trials","dateInSource":"2025-06-12","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["metreleptin"],"peptides":[{"slug":"metreleptin","url":"https://peptidescanner.com/peptides/metreleptin/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT05351164","sourceIds":["ctg-observation-nct05351164-2025-06-12-6c50d4786740"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT05351164 at 2026-11-16T17:35:38.955Z. Its registry update date was 2025-06-12, and PeptideScanner's reviewed identity mapping was metreleptin.","sourceIds":["ctg-observation-nct05351164-2025-06-12-6c50d4786740"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT05351164 at 2026-11-16T17:35:38.955Z. Its registry update date was 2025-06-12, and PeptideScanner's reviewed identity mapping was metreleptin.","sourceIds":["ctg-observation-nct05351164-2025-06-12-6c50d4786740"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct05351164-2025-06-12-6c50d4786740"]}],"sources":[{"id":"ctg-observation-nct05351164-2025-06-12-6c50d4786740","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT05351164 · retained source version 2025-06-12:6c50d4786740627d16b56d20f733c03347be67d1c336e14e177411f9bc83f0a7","url":"https://clinicaltrials.gov/study/NCT05351164"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"876ad81fa9d2e352a28b07569f1861c417a349f8fb8675eee52e8f4f9e6ce4d3","tierARecordSha256":"27c99e9fb8e2124d9077faff41792ce52a5e1fa19f6d3f97e2953bcf9a4f3582"},"integrity":{"algorithm":"sha256","contentSha256":"937243869aa65e53ad09599cfa935bcdfec6ee902a75975c800186120d96f028"}},"clinicaltrials-gov-nct06305182-metreleptin-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct06305182-metreleptin:v1","objectPathId":"clinicaltrials-gov-nct06305182-metreleptin-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct06305182-metreleptin/","json":"https://peptidescanner.com/evidence/v1/peptides/metreleptin.json#clinicaltrials-gov-nct06305182-metreleptin-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/metreleptin.md#clinicaltrials-gov-nct06305182-metreleptin-v1"},"story":{"slug":"clinicaltrials-gov-nct06305182-metreleptin","version":1,"domain":"Clinical trials","dateInSource":"2026-07-29","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["metreleptin"],"peptides":[{"slug":"metreleptin","url":"https://peptidescanner.com/peptides/metreleptin/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT06305182","sourceIds":["ctg-observation-nct06305182-2026-07-29-f98c7f9b28c5"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT06305182 at 2026-11-16T17:35:38.955Z. Its registry update date was 2026-07-29, and PeptideScanner's reviewed identity mapping was metreleptin.","sourceIds":["ctg-observation-nct06305182-2026-07-29-f98c7f9b28c5"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT06305182 at 2026-11-16T17:35:38.955Z. Its registry update date was 2026-07-29, and PeptideScanner's reviewed identity mapping was metreleptin.","sourceIds":["ctg-observation-nct06305182-2026-07-29-f98c7f9b28c5"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct06305182-2026-07-29-f98c7f9b28c5"]}],"sources":[{"id":"ctg-observation-nct06305182-2026-07-29-f98c7f9b28c5","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT06305182 · retained source version 2026-07-29:f98c7f9b28c53ffd11978b3d548c276e6bbb7ddc37d1428d4963f5fb07385e8e","url":"https://clinicaltrials.gov/study/NCT06305182"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"b49f4a5a63f56674c8df1c44991ff455a043d4bbc53e004b77fcb4dbf3c09b42","tierARecordSha256":"4c0215683aac41c652f001c66d0f5f158d4537edf507807a93a8b8a126903dfa"},"integrity":{"algorithm":"sha256","contentSha256":"826b77b94d0615a21afb32098e0826ca77741ca9367b9d0b2ed856fda1c5118f"}},"clinicaltrials-gov-nct06484868-metreleptin-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct06484868-metreleptin:v1","objectPathId":"clinicaltrials-gov-nct06484868-metreleptin-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct06484868-metreleptin/","json":"https://peptidescanner.com/evidence/v1/peptides/metreleptin.json#clinicaltrials-gov-nct06484868-metreleptin-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/metreleptin.md#clinicaltrials-gov-nct06484868-metreleptin-v1"},"story":{"slug":"clinicaltrials-gov-nct06484868-metreleptin","version":1,"domain":"Clinical trials","dateInSource":"2025-07-03","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["metreleptin"],"peptides":[{"slug":"metreleptin","url":"https://peptidescanner.com/peptides/metreleptin/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT06484868","sourceIds":["ctg-observation-nct06484868-2025-07-03-dd660667f085"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT06484868 at 2026-11-16T17:35:38.955Z. Its registry update date was 2025-07-03, and PeptideScanner's reviewed identity mapping was metreleptin.","sourceIds":["ctg-observation-nct06484868-2025-07-03-dd660667f085"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT06484868 at 2026-11-16T17:35:38.955Z. Its registry update date was 2025-07-03, and PeptideScanner's reviewed identity mapping was metreleptin.","sourceIds":["ctg-observation-nct06484868-2025-07-03-dd660667f085"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct06484868-2025-07-03-dd660667f085"]}],"sources":[{"id":"ctg-observation-nct06484868-2025-07-03-dd660667f085","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT06484868 · retained source version 2025-07-03:dd660667f085589fb3dc7d3c255d70f5036c30404f4a4c4289813002a2472412","url":"https://clinicaltrials.gov/study/NCT06484868"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"1a356ef516f02c21c0f1c7bda7bc1a42f54fdf8f8117d92eeba2648617683b71","tierARecordSha256":"3adb41caff40016e9f7a1832d90501a7ae439ec34e3ad2e929403314dff2dbdb"},"integrity":{"algorithm":"sha256","contentSha256":"bca3a05639439ea03de87f26d426fd38fa6785a350d8bcbc63860616e4306600"}},"clinicaltrials-gov-nct06679270-metreleptin-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct06679270-metreleptin:v1","objectPathId":"clinicaltrials-gov-nct06679270-metreleptin-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct06679270-metreleptin/","json":"https://peptidescanner.com/evidence/v1/peptides/metreleptin.json#clinicaltrials-gov-nct06679270-metreleptin-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/metreleptin.md#clinicaltrials-gov-nct06679270-metreleptin-v1"},"story":{"slug":"clinicaltrials-gov-nct06679270-metreleptin","version":1,"domain":"Clinical trials","dateInSource":"2026-07-16","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["metreleptin"],"peptides":[{"slug":"metreleptin","url":"https://peptidescanner.com/peptides/metreleptin/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT06679270","sourceIds":["ctg-observation-nct06679270-2026-07-16-84a988a5e075"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT06679270 at 2026-11-16T17:35:38.955Z. Its registry update date was 2026-07-16, and PeptideScanner's reviewed identity mapping was metreleptin.","sourceIds":["ctg-observation-nct06679270-2026-07-16-84a988a5e075"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT06679270 at 2026-11-16T17:35:38.955Z. Its registry update date was 2026-07-16, and PeptideScanner's reviewed identity mapping was metreleptin.","sourceIds":["ctg-observation-nct06679270-2026-07-16-84a988a5e075"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct06679270-2026-07-16-84a988a5e075"]}],"sources":[{"id":"ctg-observation-nct06679270-2026-07-16-84a988a5e075","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT06679270 · retained source version 2026-07-16:84a988a5e075bedd1192e481f00909c6d79b3f8baa679a53e46ac5a24e1fb8e8","url":"https://clinicaltrials.gov/study/NCT06679270"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"7cba25a6125265cd90c365c480f2fcaab4eca3f1a36033f14f9a0eea8f0a00a9","tierARecordSha256":"530847d670b7dad4947c8727123baf072c1ef6e1a84e3cc518562660a98cf11c"},"integrity":{"algorithm":"sha256","contentSha256":"7ef43fa0a771e3006fdc780173a3724a569fcbe0f8b079bab710071cb8a3a82f"}},"fda-drugs-bla125390-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:fda-drugs-bla125390:v1","objectPathId":"fda-drugs-bla125390-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/fda-drugs-bla125390/","json":"https://peptidescanner.com/evidence/v1/peptides/metreleptin.json#fda-drugs-bla125390-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/metreleptin.md#fda-drugs-bla125390-v1"},"story":{"slug":"fda-drugs-bla125390","version":1,"domain":"Regulatory","dateInSource":"2014-02-24","sourceCheckedAt":"2026-11-17","publishedAt":"2026-11-17","peptideSlugs":["metreleptin"],"peptides":[{"slug":"metreleptin","url":"https://peptidescanner.com/peptides/metreleptin/"}]},"claims":[{"id":"headline","text":"Drugs@FDA application BLA125390","sourceIds":["fda-drugs-bla125390-2014-02-24-ba456d7f94d7"]},{"id":"summary","text":"The official Drugs@FDA dataset lists original submission 1 for BLA 125390 with status AP dated 2014-02-24, and names metreleptin among the application record's active ingredients.","sourceIds":["fda-drugs-bla125390-2014-02-24-ba456d7f94d7"]},{"id":"paragraph-1","text":"The official Drugs@FDA dataset lists original submission 1 for BLA 125390 with status AP dated 2014-02-24, and names metreleptin among the application record's active ingredients.","sourceIds":["fda-drugs-bla125390-2014-02-24-ba456d7f94d7"]},{"id":"paragraph-2","text":"This page reports bounded application metadata attributed to Drugs@FDA. It does not reproduce labeling, describe an indication, compare products, or provide medical guidance.","sourceIds":["fda-drugs-bla125390-2014-02-24-ba456d7f94d7"]}],"sources":[{"id":"fda-drugs-bla125390-2014-02-24-ba456d7f94d7","name":"Drugs@FDA via openFDA","sourceClass":"A","title":"Drugs@FDA application BLA125390 · original submission status AP · 2014-02-24 · dataset 2026-11-16","url":"https://api.fda.gov/drug/drugsfda.json?search=application_number%3A%22BLA125390%22&limit=1"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"f729f32832b85d2917937c4143002995ebf4fb20c016ac3229600862dfa3ef41","tierARecordSha256":"ba456d7f94d7e95364d286aa2bd7835db13d6f73abedaa53d5c7d31171a28dcc"},"integrity":{"algorithm":"sha256","contentSha256":"c416f3333b101cadf855f73abd4c5ca3aa19182b99e2f18d480e102b779282b2"}},"federal-register-2013-25588-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:federal-register-2013-25588:v1","objectPathId":"federal-register-2013-25588-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/federal-register-2013-25588/","json":"https://peptidescanner.com/evidence/v1/peptides/metreleptin.json#federal-register-2013-25588-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/metreleptin.md#federal-register-2013-25588-v1"},"story":{"slug":"federal-register-2013-25588","version":1,"domain":"Regulatory","dateInSource":"2013-10-30","sourceCheckedAt":"2026-11-17","publishedAt":"2026-11-17","peptideSlugs":["metreleptin"],"peptides":[{"slug":"metreleptin","url":"https://peptidescanner.com/peptides/metreleptin/"}]},"claims":[{"id":"headline","text":"Federal Register notice 2013-25588","sourceIds":["federal-register-2013-25588-0f614a94a390"]},{"id":"summary","text":"The Federal Register published notice 2013-25588, attributed to FDA and its parent HHS department, on 2013-10-30. Its official title is “Endocrinologic and Metabolic Drugs Advisory Committee; Notice of Meeting,” and PeptideScanner's exact reviewed identity mapping connects the document to Metreleptin.","sourceIds":["federal-register-2013-25588-0f614a94a390"]},{"id":"paragraph-1","text":"The Federal Register published notice 2013-25588, attributed to FDA and its parent HHS department, on 2013-10-30. Its official title is “Endocrinologic and Metabolic Drugs Advisory Committee; Notice of Meeting,” and PeptideScanner's exact reviewed identity mapping connects the document to Metreleptin.","sourceIds":["federal-register-2013-25588-0f614a94a390"]},{"id":"paragraph-2","text":"This page reports bounded metadata from a Federal Register document attributed to FDA and its parent HHS department, and links to the official GovInfo PDF. It does not interpret legal effect, approval, safety, effectiveness, compounding status, or medical use.","sourceIds":["federal-register-2013-25588-0f614a94a390"]}],"sources":[{"id":"federal-register-2013-25588-0f614a94a390","name":"Federal Register via GovInfo","sourceClass":"A","title":"Federal Register notice 2013-25588 · published 2013-10-30 · Endocrinologic and Metabolic Drugs Advisory Committee; Notice of Meeting","url":"https://www.govinfo.gov/content/pkg/FR-2013-10-30/pdf/2013-25588.pdf"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"100934706ed7c819b7b6cea4e0d8cce6c0f841e7852913490a4611e907a73127","tierARecordSha256":"0f614a94a390a40587d044523557e83c19c6a1e8adf95fa1cbeca6433097df80"},"integrity":{"algorithm":"sha256","contentSha256":"f557b1aff56b5a23e39f46b3b06fc3360cbfb08707f40dfada8e380398a0b43b"}},"federal-register-2016-22935-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:federal-register-2016-22935:v1","objectPathId":"federal-register-2016-22935-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/federal-register-2016-22935/","json":"https://peptidescanner.com/evidence/v1/peptides/metreleptin.json#federal-register-2016-22935-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/metreleptin.md#federal-register-2016-22935-v1"},"story":{"slug":"federal-register-2016-22935","version":1,"domain":"Regulatory","dateInSource":"2016-09-23","sourceCheckedAt":"2026-11-17","publishedAt":"2026-11-17","peptideSlugs":["metreleptin"],"peptides":[{"slug":"metreleptin","url":"https://peptidescanner.com/peptides/metreleptin/"}]},"claims":[{"id":"headline","text":"Federal Register notice 2016-22935","sourceIds":["federal-register-2016-22935-6e9cbee524d2"]},{"id":"summary","text":"The Federal Register published notice 2016-22935, attributed to FDA and its parent HHS department, on 2016-09-23. Its official title is “Determination of Regulatory Review Period for Purposes of Patent Extension; MYALEPT,” and PeptideScanner's exact reviewed identity mapping connects the document to Metreleptin.","sourceIds":["federal-register-2016-22935-6e9cbee524d2"]},{"id":"paragraph-1","text":"The Federal Register published notice 2016-22935, attributed to FDA and its parent HHS department, on 2016-09-23. Its official title is “Determination of Regulatory Review Period for Purposes of Patent Extension; MYALEPT,” and PeptideScanner's exact reviewed identity mapping connects the document to Metreleptin.","sourceIds":["federal-register-2016-22935-6e9cbee524d2"]},{"id":"paragraph-2","text":"This page reports bounded metadata from a Federal Register document attributed to FDA and its parent HHS department, and links to the official GovInfo PDF. It does not interpret legal effect, approval, safety, effectiveness, compounding status, or medical use.","sourceIds":["federal-register-2016-22935-6e9cbee524d2"]}],"sources":[{"id":"federal-register-2016-22935-6e9cbee524d2","name":"Federal Register via GovInfo","sourceClass":"A","title":"Federal Register notice 2016-22935 · published 2016-09-23 · Determination of Regulatory Review Period for Purposes of Patent Extension; MYALEPT","url":"https://www.govinfo.gov/content/pkg/FR-2016-09-23/pdf/2016-22935.pdf"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"e02f37177b2e40d336a00a68a4d4ea3ed3ddc847693743d88acf918889a297cb","tierARecordSha256":"6e9cbee524d2c29ddd3d35efaf49a0ce30d49cec79305b628c6f9c285dd23e9b"},"integrity":{"algorithm":"sha256","contentSha256":"3c5ba1f5e955dc81306a6482e18f060a3f38243345fd24168f712fd122656db0"}},"pubmed-pmid-11184472-metreleptin-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-11184472-metreleptin:v1","objectPathId":"pubmed-pmid-11184472-metreleptin-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-11184472-metreleptin/","json":"https://peptidescanner.com/evidence/v1/peptides/metreleptin.json#pubmed-pmid-11184472-metreleptin-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/metreleptin.md#pubmed-pmid-11184472-metreleptin-v1"},"story":{"slug":"pubmed-pmid-11184472-metreleptin","version":1,"domain":"Literature metadata","dateInSource":"2017-11-16","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["metreleptin"],"peptides":[{"slug":"metreleptin","url":"https://peptidescanner.com/peptides/metreleptin/"}]},"claims":[{"id":"headline","text":"USAN Council. List No.431. New names. Metreleptin.","sourceIds":["pubmed-observation-pmid-11184472-2017-11-16-4979554b23ee"]},{"id":"summary","text":"PubMed lists PMID 11184472 in Clinical pharmacology and therapeutics as Journal Article, with publication-date metadata of 2000-10 (month precision). PeptideScanner associated the retained record with the identity slug metreleptin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-11184472-2017-11-16-4979554b23ee"]},{"id":"paragraph-1","text":"PubMed lists PMID 11184472 in Clinical pharmacology and therapeutics as Journal Article, with publication-date metadata of 2000-10 (month precision). PeptideScanner associated the retained record with the identity slug metreleptin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-11184472-2017-11-16-4979554b23ee"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-11184472-2017-11-16-4979554b23ee"]}],"sources":[{"id":"pubmed-observation-pmid-11184472-2017-11-16-4979554b23ee","name":"PubMed","sourceClass":"A","title":"USAN Council. List No.431. New names. Metreleptin. · retained source version 1:2017-11-16:current:4979554b23ee1bd39b28cc79804c87ec03d0db67c4500122ec687cf5b11c5e9d","url":"https://pubmed.ncbi.nlm.nih.gov/11184472/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"6d9428ef74e868c9d4781a59c069e6b87be1332244ed95d7eca59844c878514f","tierARecordSha256":"5f60971b30a72fff8258c45e556fd395400fe9a4c13b90576c9da299cb3048f5"},"integrity":{"algorithm":"sha256","contentSha256":"211630e0d9049d80f69d338dafd6e001e13c38ccf489abfb8d5ff6072d12eb67"}},"pubmed-pmid-20350904-metreleptin-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-20350904-metreleptin:v1","objectPathId":"pubmed-pmid-20350904-metreleptin-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-20350904-metreleptin/","json":"https://peptidescanner.com/evidence/v1/peptides/metreleptin.json#pubmed-pmid-20350904-metreleptin-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/metreleptin.md#pubmed-pmid-20350904-metreleptin-v1"},"story":{"slug":"pubmed-pmid-20350904-metreleptin","version":1,"domain":"Literature metadata","dateInSource":"2021-02-04","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["metreleptin"],"peptides":[{"slug":"metreleptin","url":"https://peptidescanner.com/peptides/metreleptin/"}]},"claims":[{"id":"headline","text":"W(h)ither metreleptin for lipodystrophy and the metabolic syndrome?","sourceIds":["pubmed-observation-pmid-20350904-2021-02-04-1d0c5810f37e"]},{"id":"summary","text":"PubMed lists PMID 20350904 in Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists as Editorial, Comment, with publication-date metadata of 2010 Mar-Apr (source-text precision). PeptideScanner associated the retained record with the identity slug metreleptin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-20350904-2021-02-04-1d0c5810f37e"]},{"id":"paragraph-1","text":"PubMed lists PMID 20350904 in Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists as Editorial, Comment, with publication-date metadata of 2010 Mar-Apr (source-text precision). PeptideScanner associated the retained record with the identity slug metreleptin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-20350904-2021-02-04-1d0c5810f37e"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-20350904-2021-02-04-1d0c5810f37e"]}],"sources":[{"id":"pubmed-observation-pmid-20350904-2021-02-04-1d0c5810f37e","name":"PubMed","sourceClass":"A","title":"W(h)ither metreleptin for lipodystrophy and the metabolic syndrome? · retained source version 1:2021-02-04:current:1d0c5810f37ea51232730bd8508dbffef20edf2c35fbe307ec82f356a0d2c5e8","url":"https://pubmed.ncbi.nlm.nih.gov/20350904/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"0302214d165c0d91cc8bb151c0c3108105c941c38d2fd4b7fc6a58b8af4540dd","tierARecordSha256":"7cabbac53b250a7a9783861da9acb0b5fc14e544bac381d123b2accfe30e892b"},"integrity":{"algorithm":"sha256","contentSha256":"3a1f2c962c2848ec09e866f81aa3b7349f87722c18289cac48556908d606d7f8"}},"pubmed-pmid-25070319-metreleptin-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-25070319-metreleptin:v1","objectPathId":"pubmed-pmid-25070319-metreleptin-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-25070319-metreleptin/","json":"https://peptidescanner.com/evidence/v1/peptides/metreleptin.json#pubmed-pmid-25070319-metreleptin-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/metreleptin.md#pubmed-pmid-25070319-metreleptin-v1"},"story":{"slug":"pubmed-pmid-25070319-metreleptin","version":1,"domain":"Literature metadata","dateInSource":"2023-04-11","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["metreleptin"],"peptides":[{"slug":"metreleptin","url":"https://peptidescanner.com/peptides/metreleptin/"}]},"claims":[{"id":"headline","text":"Bone mineral content in patients with congenital generalized lipodystrophy is unaffected by metreleptin replacement therapy.","sourceIds":["pubmed-observation-pmid-25070319-2023-04-11-9a8aac78ae26"]},{"id":"summary","text":"PubMed lists PMID 25070319 in The Journal of clinical endocrinology and metabolism as Controlled Clinical Trial, Journal Article, Research Support, N.I.H., Intramural, with publication-date metadata of 2014-07-29 (day precision). PeptideScanner associated the retained record with the identity slug metreleptin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-25070319-2023-04-11-9a8aac78ae26"]},{"id":"paragraph-1","text":"PubMed lists PMID 25070319 in The Journal of clinical endocrinology and metabolism as Controlled Clinical Trial, Journal Article, Research Support, N.I.H., Intramural, with publication-date metadata of 2014-07-29 (day precision). PeptideScanner associated the retained record with the identity slug metreleptin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-25070319-2023-04-11-9a8aac78ae26"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-25070319-2023-04-11-9a8aac78ae26"]}],"sources":[{"id":"pubmed-observation-pmid-25070319-2023-04-11-9a8aac78ae26","name":"PubMed","sourceClass":"A","title":"Bone mineral content in patients with congenital generalized lipodystrophy is unaffected by metreleptin replacement therapy. · retained source version 1:2023-04-11:current:9a8aac78ae26c44796ed9d86c7d1a50bd5a741b765b813c42ad696a82b936d5e","url":"https://pubmed.ncbi.nlm.nih.gov/25070319/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"78f8965ae14b2df0466898c1cd3121aadeaf987be06b6ca9505daa55539a0bea","tierARecordSha256":"9f6e3fa3a71ed6c714285be56516f1491e211c69a5817f43026e6ed2a20ca9f5"},"integrity":{"algorithm":"sha256","contentSha256":"b888d0cfdb0383593a32ba9eed73a095f7525e636dbccabf50c20522aaa1b88b"}},"pubmed-pmid-25581107-metreleptin-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-25581107-metreleptin:v1","objectPathId":"pubmed-pmid-25581107-metreleptin-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-25581107-metreleptin/","json":"https://peptidescanner.com/evidence/v1/peptides/metreleptin.json#pubmed-pmid-25581107-metreleptin-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/metreleptin.md#pubmed-pmid-25581107-metreleptin-v1"},"story":{"slug":"pubmed-pmid-25581107-metreleptin","version":1,"domain":"Literature metadata","dateInSource":"2017-11-16","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["metreleptin"],"peptides":[{"slug":"metreleptin","url":"https://peptidescanner.com/peptides/metreleptin/"}]},"claims":[{"id":"headline","text":"Metreleptin (Myalept): a leptin analog for generalized lipodystrophy.","sourceIds":["pubmed-observation-pmid-25581107-2017-11-16-e00746c16fcb"]},{"id":"summary","text":"PubMed lists PMID 25581107 in The Medical letter on drugs and therapeutics as Journal Article, Review, with publication-date metadata of 2015-01-19 (day precision). PeptideScanner associated the retained record with the identity slug metreleptin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-25581107-2017-11-16-e00746c16fcb"]},{"id":"paragraph-1","text":"PubMed lists PMID 25581107 in The Medical letter on drugs and therapeutics as Journal Article, Review, with publication-date metadata of 2015-01-19 (day precision). PeptideScanner associated the retained record with the identity slug metreleptin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-25581107-2017-11-16-e00746c16fcb"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-25581107-2017-11-16-e00746c16fcb"]}],"sources":[{"id":"pubmed-observation-pmid-25581107-2017-11-16-e00746c16fcb","name":"PubMed","sourceClass":"A","title":"Metreleptin (Myalept): a leptin analog for generalized lipodystrophy. · retained source version 1:2017-11-16:current:e00746c16fcbe47a47b5ce0d068bab2e1a876fc8ee281e5046b5c667dfc524ec","url":"https://pubmed.ncbi.nlm.nih.gov/25581107/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"0803916865ce97d1ddb8d0c8d88692c7a051ab4a6a78221319e7feeab0d21bbc","tierARecordSha256":"c46e3cb616472dd295d70511927ab65b7831872f5076169cbf06b27cc26612ae"},"integrity":{"algorithm":"sha256","contentSha256":"c55ac1bb32d09011a5973c319a705c2b2717d3077faa8d4bd30c0ab1ceb3e7b6"}},"pubmed-pmid-26063386-metreleptin-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-26063386-metreleptin:v1","objectPathId":"pubmed-pmid-26063386-metreleptin-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-26063386-metreleptin/","json":"https://peptidescanner.com/evidence/v1/peptides/metreleptin.json#pubmed-pmid-26063386-metreleptin-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/metreleptin.md#pubmed-pmid-26063386-metreleptin-v1"},"story":{"slug":"pubmed-pmid-26063386-metreleptin","version":1,"domain":"Literature metadata","dateInSource":"2018-12-02","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["metreleptin"],"peptides":[{"slug":"metreleptin","url":"https://peptidescanner.com/peptides/metreleptin/"}]},"claims":[{"id":"headline","text":"Metreleptin and generalized lipodystrophy and evolving therapeutic perspectives.","sourceIds":["pubmed-observation-pmid-26063386-2018-12-02-ff4e82d1a0df"]},{"id":"summary","text":"PubMed lists PMID 26063386 in Expert opinion on biological therapy as Journal Article, Review, with publication-date metadata of 2015-07 (month precision). PeptideScanner associated the retained record with the identity slug metreleptin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-26063386-2018-12-02-ff4e82d1a0df"]},{"id":"paragraph-1","text":"PubMed lists PMID 26063386 in Expert opinion on biological therapy as Journal Article, Review, with publication-date metadata of 2015-07 (month precision). PeptideScanner associated the retained record with the identity slug metreleptin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-26063386-2018-12-02-ff4e82d1a0df"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-26063386-2018-12-02-ff4e82d1a0df"]}],"sources":[{"id":"pubmed-observation-pmid-26063386-2018-12-02-ff4e82d1a0df","name":"PubMed","sourceClass":"A","title":"Metreleptin and generalized lipodystrophy and evolving therapeutic perspectives. · retained source version 1:2018-12-02:current:ff4e82d1a0dfd4bbb54a28e1e5a2169de871c5e22200e18fb5a60c7e1bb6acdb","url":"https://pubmed.ncbi.nlm.nih.gov/26063386/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"fd6db4e5c975470f496022a1b3f761285924d23c1ca332bd83946cfb6546a9d7","tierARecordSha256":"57437e01504109fc97cf779fbca9dbb2c52915833313fadc536f3dabdf603546"},"integrity":{"algorithm":"sha256","contentSha256":"33f112e8d82ce38a8bd29cd95204104608207fbf982e9095e3915a633aafeb68"}},"pubmed-pmid-26396524-metreleptin-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-26396524-metreleptin:v1","objectPathId":"pubmed-pmid-26396524-metreleptin-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-26396524-metreleptin/","json":"https://peptidescanner.com/evidence/v1/peptides/metreleptin.json#pubmed-pmid-26396524-metreleptin-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/metreleptin.md#pubmed-pmid-26396524-metreleptin-v1"},"story":{"slug":"pubmed-pmid-26396524-metreleptin","version":1,"domain":"Literature metadata","dateInSource":"2024-03-23","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["metreleptin"],"peptides":[{"slug":"metreleptin","url":"https://peptidescanner.com/peptides/metreleptin/"}]},"claims":[{"id":"headline","text":"New advances in the treatment of generalized lipodystrophy: role of metreleptin.","sourceIds":["pubmed-observation-pmid-26396524-2024-03-23-0514676dda07"]},{"id":"summary","text":"PubMed lists PMID 26396524 in Therapeutics and clinical risk management as Journal Article, Review, with publication-date metadata of 2015-09-16 (day precision). PeptideScanner associated the retained record with the identity slug metreleptin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-26396524-2024-03-23-0514676dda07"]},{"id":"paragraph-1","text":"PubMed lists PMID 26396524 in Therapeutics and clinical risk management as Journal Article, Review, with publication-date metadata of 2015-09-16 (day precision). PeptideScanner associated the retained record with the identity slug metreleptin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-26396524-2024-03-23-0514676dda07"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-26396524-2024-03-23-0514676dda07"]}],"sources":[{"id":"pubmed-observation-pmid-26396524-2024-03-23-0514676dda07","name":"PubMed","sourceClass":"A","title":"New advances in the treatment of generalized lipodystrophy: role of metreleptin. · retained source version 1:2024-03-23:current:0514676dda077b168d5ed9a63dc43224412af683303a799bcbae529f7f6f6d72","url":"https://pubmed.ncbi.nlm.nih.gov/26396524/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"c4df338b8623a89b7dae96a4aa401b9305c9802db20a7c6256950989927e5619","tierARecordSha256":"4fed3ba0472c7bb1e4767e5e8a4f724c368d3ca14ebfd0d01748ce0ee858de87"},"integrity":{"algorithm":"sha256","contentSha256":"7e3c0e4a4dea37d38217724e8fbe5f2b1cdb0b6c09a24168aab698ec1ab3565a"}},"pubmed-pmid-27717125-metreleptin-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-27717125-metreleptin:v1","objectPathId":"pubmed-pmid-27717125-metreleptin-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-27717125-metreleptin/","json":"https://peptidescanner.com/evidence/v1/peptides/metreleptin.json#pubmed-pmid-27717125-metreleptin-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/metreleptin.md#pubmed-pmid-27717125-metreleptin-v1"},"story":{"slug":"pubmed-pmid-27717125-metreleptin","version":1,"domain":"Literature metadata","dateInSource":"2026-01-27","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["metreleptin"],"peptides":[{"slug":"metreleptin","url":"https://peptidescanner.com/peptides/metreleptin/"}]},"claims":[{"id":"headline","text":"First metreleptin treatment for generalized lipodystrophy in Turkey.","sourceIds":["pubmed-observation-pmid-27717125-2026-01-27-8aa206d36eab"]},{"id":"summary","text":"PubMed lists PMID 27717125 in Diabetes, obesity & metabolism as Case Reports, Letter, with publication-date metadata of 2016-11-09 (day precision). PeptideScanner associated the retained record with the identity slug metreleptin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-27717125-2026-01-27-8aa206d36eab"]},{"id":"paragraph-1","text":"PubMed lists PMID 27717125 in Diabetes, obesity & metabolism as Case Reports, Letter, with publication-date metadata of 2016-11-09 (day precision). PeptideScanner associated the retained record with the identity slug metreleptin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-27717125-2026-01-27-8aa206d36eab"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-27717125-2026-01-27-8aa206d36eab"]}],"sources":[{"id":"pubmed-observation-pmid-27717125-2026-01-27-8aa206d36eab","name":"PubMed","sourceClass":"A","title":"First metreleptin treatment for generalized lipodystrophy in Turkey. · retained source version 1:2026-01-27:current:8aa206d36eab69da6bcd4579ed2a3e4bca5ff522621b0cc6938a8d13fae5f687","url":"https://pubmed.ncbi.nlm.nih.gov/27717125/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"41965697f6a92761ea40bb76a7956dea1976eeb257c42571376179d0117c04d6","tierARecordSha256":"7995a8008599d7627c2c2b09bc57cab0d9880411f8640c2045ee5beddc5e2d53"},"integrity":{"algorithm":"sha256","contentSha256":"eeff8d2b63bf5c1e93c686e06517fdb9aed85d116ddce29092159b860f80139b"}},"pubmed-pmid-30745727-metreleptin-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-30745727-metreleptin:v1","objectPathId":"pubmed-pmid-30745727-metreleptin-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-30745727-metreleptin/","json":"https://peptidescanner.com/evidence/v1/peptides/metreleptin.json#pubmed-pmid-30745727-metreleptin-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/metreleptin.md#pubmed-pmid-30745727-metreleptin-v1"},"story":{"slug":"pubmed-pmid-30745727-metreleptin","version":1,"domain":"Literature metadata","dateInSource":"2020-09-30","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["metreleptin"],"peptides":[{"slug":"metreleptin","url":"https://peptidescanner.com/peptides/metreleptin/"}]},"claims":[{"id":"headline","text":"Metreleptin treatment for congenital generalized lipodystrophy type 4 (CGL4): a case report.","sourceIds":["pubmed-observation-pmid-30745727-2020-09-30-56409ac4e25d"]},{"id":"summary","text":"PubMed lists PMID 30745727 in Clinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology as Journal Article, with publication-date metadata of 2019-01-31 (day precision). PeptideScanner associated the retained record with the identity slug metreleptin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-30745727-2020-09-30-56409ac4e25d"]},{"id":"paragraph-1","text":"PubMed lists PMID 30745727 in Clinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology as Journal Article, with publication-date metadata of 2019-01-31 (day precision). PeptideScanner associated the retained record with the identity slug metreleptin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-30745727-2020-09-30-56409ac4e25d"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-30745727-2020-09-30-56409ac4e25d"]}],"sources":[{"id":"pubmed-observation-pmid-30745727-2020-09-30-56409ac4e25d","name":"PubMed","sourceClass":"A","title":"Metreleptin treatment for congenital generalized lipodystrophy type 4 (CGL4): a case report. · retained source version 1:2020-09-30:current:56409ac4e25dbaa8a605d7ce42cf44975700732a895ef344a4c7633e09e473b2","url":"https://pubmed.ncbi.nlm.nih.gov/30745727/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"2eab744f09cc1f020b2795c4e21958dcbdbbce36b94c5fd3050fa7023bbcff11","tierARecordSha256":"ec8195c3d78c40e4a8facfce7a69943de2c1b60ee644353c179af7c8111f952f"},"integrity":{"algorithm":"sha256","contentSha256":"9904f6eb51fa02ba688185ba35717b98e9b976da227f5373871bdf578ae25199"}},"pubmed-pmid-30923630-metreleptin-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-30923630-metreleptin:v1","objectPathId":"pubmed-pmid-30923630-metreleptin-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-30923630-metreleptin/","json":"https://peptidescanner.com/evidence/v1/peptides/metreleptin.json#pubmed-pmid-30923630-metreleptin-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/metreleptin.md#pubmed-pmid-30923630-metreleptin-v1"},"story":{"slug":"pubmed-pmid-30923630-metreleptin","version":1,"domain":"Literature metadata","dateInSource":"2022-04-08","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["metreleptin"],"peptides":[{"slug":"metreleptin","url":"https://peptidescanner.com/peptides/metreleptin/"}]},"claims":[{"id":"headline","text":"Diagnosis of acquired generalized lipodystrophy in a single patient with T-cell lymphoma and no exposure to Metreleptin.","sourceIds":["pubmed-observation-pmid-30923630-2022-04-08-6dea7a511c8a"]},{"id":"summary","text":"PubMed lists PMID 30923630 in Clinical diabetes and endocrinology as Case Reports, Journal Article, with publication-date metadata of 2019-03-14 (day precision). PeptideScanner associated the retained record with the identity slug metreleptin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-30923630-2022-04-08-6dea7a511c8a"]},{"id":"paragraph-1","text":"PubMed lists PMID 30923630 in Clinical diabetes and endocrinology as Case Reports, Journal Article, with publication-date metadata of 2019-03-14 (day precision). PeptideScanner associated the retained record with the identity slug metreleptin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-30923630-2022-04-08-6dea7a511c8a"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-30923630-2022-04-08-6dea7a511c8a"]}],"sources":[{"id":"pubmed-observation-pmid-30923630-2022-04-08-6dea7a511c8a","name":"PubMed","sourceClass":"A","title":"Diagnosis of acquired generalized lipodystrophy in a single patient with T-cell lymphoma and no exposure to Metreleptin. · retained source version 1:2022-04-08:current:6dea7a511c8a2b37cd1abe375b41b75bb8edfacd58b011405271d67e5748bb7c","url":"https://pubmed.ncbi.nlm.nih.gov/30923630/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"7f9b6a3c2355c5ebdf769e0fb6251415885afe9d7d52694b1629f42b8e783dec","tierARecordSha256":"bb8985f8fbd59b101d5fc5d8e0f9b224b5fcc0c1d4dee516f72dc3532ca0513f"},"integrity":{"algorithm":"sha256","contentSha256":"e1621a23ee62d8f97e1762649d921cfa219ce5f48e7a167340152746b5bb999a"}},"pubmed-pmid-31300002-metreleptin-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-31300002-metreleptin:v1","objectPathId":"pubmed-pmid-31300002-metreleptin-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-31300002-metreleptin/","json":"https://peptidescanner.com/evidence/v1/peptides/metreleptin.json#pubmed-pmid-31300002-metreleptin-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/metreleptin.md#pubmed-pmid-31300002-metreleptin-v1"},"story":{"slug":"pubmed-pmid-31300002-metreleptin","version":1,"domain":"Literature metadata","dateInSource":"2020-04-27","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["metreleptin"],"peptides":[{"slug":"metreleptin","url":"https://peptidescanner.com/peptides/metreleptin/"}]},"claims":[{"id":"headline","text":"Adherence with metreleptin therapy and health self-perception in patients with lipodystrophic syndromes.","sourceIds":["pubmed-observation-pmid-31300002-2020-04-27-0bdf624c6ce7"]},{"id":"summary","text":"PubMed lists PMID 31300002 in Orphanet journal of rare diseases as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2019-07-12 (day precision). PeptideScanner associated the retained record with the identity slug metreleptin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-31300002-2020-04-27-0bdf624c6ce7"]},{"id":"paragraph-1","text":"PubMed lists PMID 31300002 in Orphanet journal of rare diseases as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2019-07-12 (day precision). PeptideScanner associated the retained record with the identity slug metreleptin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-31300002-2020-04-27-0bdf624c6ce7"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-31300002-2020-04-27-0bdf624c6ce7"]}],"sources":[{"id":"pubmed-observation-pmid-31300002-2020-04-27-0bdf624c6ce7","name":"PubMed","sourceClass":"A","title":"Adherence with metreleptin therapy and health self-perception in patients with lipodystrophic syndromes. · retained source version 1:2020-04-27:current:0bdf624c6ce7456976697ee6c4830fe2a0598a9849f4d2bdb8f15a3fad481611","url":"https://pubmed.ncbi.nlm.nih.gov/31300002/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"51bbe7bb27099bd3d04ad0ab59d471b86a8b81bb1833ab61304f61a216a2e208","tierARecordSha256":"f0ca1ed3f6e5f765671bd2705f2be8225a5117947aae2cc1ae5d0f74a5dfc629"},"integrity":{"algorithm":"sha256","contentSha256":"c892d1386c20d81b187c5d0d3f4c74c3c9f747d29be5769344911dc966b9e53f"}},"pubmed-pmid-33099310-metreleptin-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-33099310-metreleptin:v1","objectPathId":"pubmed-pmid-33099310-metreleptin-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-33099310-metreleptin/","json":"https://peptidescanner.com/evidence/v1/peptides/metreleptin.json#pubmed-pmid-33099310-metreleptin-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/metreleptin.md#pubmed-pmid-33099310-metreleptin-v1"},"story":{"slug":"pubmed-pmid-33099310-metreleptin","version":1,"domain":"Literature metadata","dateInSource":"2021-08-26","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["metreleptin"],"peptides":[{"slug":"metreleptin","url":"https://peptidescanner.com/peptides/metreleptin/"}]},"claims":[{"id":"headline","text":"Metreleptin for the treatment of progressive encephalopathy with/without lipodystrophy (PELD) in a child with progressive myoclonic epilepsy: a case report.","sourceIds":["pubmed-observation-pmid-33099310-2021-08-26-ea193dcbaf0d"]},{"id":"summary","text":"PubMed lists PMID 33099310 in Italian journal of pediatrics as Case Reports, Journal Article, with publication-date metadata of 2020-10-24 (day precision). PeptideScanner associated the retained record with the identity slug metreleptin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-33099310-2021-08-26-ea193dcbaf0d"]},{"id":"paragraph-1","text":"PubMed lists PMID 33099310 in Italian journal of pediatrics as Case Reports, Journal Article, with publication-date metadata of 2020-10-24 (day precision). PeptideScanner associated the retained record with the identity slug metreleptin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-33099310-2021-08-26-ea193dcbaf0d"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-33099310-2021-08-26-ea193dcbaf0d"]}],"sources":[{"id":"pubmed-observation-pmid-33099310-2021-08-26-ea193dcbaf0d","name":"PubMed","sourceClass":"A","title":"Metreleptin for the treatment of progressive encephalopathy with/without lipodystrophy (PELD) in a child with progressive myoclonic epilepsy: a case report. · retained source version 1:2021-08-26:current:ea193dcbaf0d309516fe08261c17b4af5632d7bd31c25f814c7758ce22437b6d","url":"https://pubmed.ncbi.nlm.nih.gov/33099310/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"542a7656e73f1a3a1b422bd73f4734f0874d832824335e1ed5ab7e867eee37d6","tierARecordSha256":"9f17d485364b09f077b90c1759edc34098c6a1f6835961e81d1ffddbcd940464"},"integrity":{"algorithm":"sha256","contentSha256":"01775dc86d8abfb1655466e4359cd1fbb4916044f0dc13a98383fa2f278fba53"}},"pubmed-pmid-34571177-metreleptin-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-34571177-metreleptin:v1","objectPathId":"pubmed-pmid-34571177-metreleptin-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-34571177-metreleptin/","json":"https://peptidescanner.com/evidence/v1/peptides/metreleptin.json#pubmed-pmid-34571177-metreleptin-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/metreleptin.md#pubmed-pmid-34571177-metreleptin-v1"},"story":{"slug":"pubmed-pmid-34571177-metreleptin","version":1,"domain":"Literature metadata","dateInSource":"2026-11-09","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["metreleptin"],"peptides":[{"slug":"metreleptin","url":"https://peptidescanner.com/peptides/metreleptin/"}]},"claims":[{"id":"headline","text":"Metreleptin treatment of non-HIV lipodystrophy syndromes.","sourceIds":["pubmed-observation-pmid-34571177-2026-11-09-92dd720f3745"]},{"id":"summary","text":"PubMed lists PMID 34571177 in Presse medicale (Paris, France : 1983) as Journal Article, Review, with publication-date metadata of 2021-09-24 (day precision). PeptideScanner associated the retained record with the identity slug metreleptin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-34571177-2026-11-09-92dd720f3745"]},{"id":"paragraph-1","text":"PubMed lists PMID 34571177 in Presse medicale (Paris, France : 1983) as Journal Article, Review, with publication-date metadata of 2021-09-24 (day precision). PeptideScanner associated the retained record with the identity slug metreleptin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-34571177-2026-11-09-92dd720f3745"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-34571177-2026-11-09-92dd720f3745"]}],"sources":[{"id":"pubmed-observation-pmid-34571177-2026-11-09-92dd720f3745","name":"PubMed","sourceClass":"A","title":"Metreleptin treatment of non-HIV lipodystrophy syndromes. · retained source version 1:2026-11-09:current:92dd720f374578896c5a9aaa9a7c88d8d096164edd4d2343f5cd2592b0bfbd3a","url":"https://pubmed.ncbi.nlm.nih.gov/34571177/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"b5255005842f10bf73d9f0dc2e7af9e267c07037ec5934291b7fde19c5e56482","tierARecordSha256":"219a41e64ad1760d578f7d04eb9c84ab192c3c8e6ced5e9a78b939712a52f6b5"},"integrity":{"algorithm":"sha256","contentSha256":"e4efd47d60ff8ae0f237bf7187d261b4203896be58b9c39cadf4c300f063f003"}},"pubmed-pmid-40860570-metreleptin-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-40860570-metreleptin:v1","objectPathId":"pubmed-pmid-40860570-metreleptin-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-40860570-metreleptin/","json":"https://peptidescanner.com/evidence/v1/peptides/metreleptin.json#pubmed-pmid-40860570-metreleptin-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/metreleptin.md#pubmed-pmid-40860570-metreleptin-v1"},"story":{"slug":"pubmed-pmid-40860570-metreleptin","version":1,"domain":"Literature metadata","dateInSource":"2025-09-14","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["metreleptin"],"peptides":[{"slug":"metreleptin","url":"https://peptidescanner.com/peptides/metreleptin/"}]},"claims":[{"id":"headline","text":"Long-Term Clinical Experience With Metreleptin in a Brazilian Patient With Congenital Generalized Lipodystrophy Type 2.","sourceIds":["pubmed-observation-pmid-40860570-2025-09-14-c0dad1492d2b"]},{"id":"summary","text":"PubMed lists PMID 40860570 in JCEM case reports as Case Reports, Journal Article, with publication-date metadata of 2025-08-22 (day precision). PeptideScanner associated the retained record with the identity slug metreleptin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-40860570-2025-09-14-c0dad1492d2b"]},{"id":"paragraph-1","text":"PubMed lists PMID 40860570 in JCEM case reports as Case Reports, Journal Article, with publication-date metadata of 2025-08-22 (day precision). PeptideScanner associated the retained record with the identity slug metreleptin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-40860570-2025-09-14-c0dad1492d2b"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-40860570-2025-09-14-c0dad1492d2b"]}],"sources":[{"id":"pubmed-observation-pmid-40860570-2025-09-14-c0dad1492d2b","name":"PubMed","sourceClass":"A","title":"Long-Term Clinical Experience With Metreleptin in a Brazilian Patient With Congenital Generalized Lipodystrophy Type 2. · retained source version 1:2025-09-14:current:c0dad1492d2bd6955cd26a680d36a198f73799b802ab9d1d9e9f2be08dd651f6","url":"https://pubmed.ncbi.nlm.nih.gov/40860570/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"9bd1f279ae8f22c4b4da85ad63e46387c2d5b901cda80428fbd468126ce3c4ac","tierARecordSha256":"d994f74d5d0f36e597e51b68dca67a65afa7cc575aa8b35937589fd49072d847"},"integrity":{"algorithm":"sha256","contentSha256":"7034a1d0d5de8041933261cb9dc1a659cc2bc62bf52de53c79e8fceb7c387d54"}},"pubmed-pmid-41080980-metreleptin-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-41080980-metreleptin:v1","objectPathId":"pubmed-pmid-41080980-metreleptin-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-41080980-metreleptin/","json":"https://peptidescanner.com/evidence/v1/peptides/metreleptin.json#pubmed-pmid-41080980-metreleptin-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/metreleptin.md#pubmed-pmid-41080980-metreleptin-v1"},"story":{"slug":"pubmed-pmid-41080980-metreleptin","version":1,"domain":"Literature metadata","dateInSource":"2025-10-15","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["metreleptin"],"peptides":[{"slug":"metreleptin","url":"https://peptidescanner.com/peptides/metreleptin/"}]},"claims":[{"id":"headline","text":"Metreleptin In SHORT Syndrome With Uncontrolled Diabetes.","sourceIds":["pubmed-observation-pmid-41080980-2025-10-15-853ee76241eb"]},{"id":"summary","text":"PubMed lists PMID 41080980 in JCEM case reports as Case Reports, Journal Article, with publication-date metadata of 2025-10-09 (day precision). PeptideScanner associated the retained record with the identity slug metreleptin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-41080980-2025-10-15-853ee76241eb"]},{"id":"paragraph-1","text":"PubMed lists PMID 41080980 in JCEM case reports as Case Reports, Journal Article, with publication-date metadata of 2025-10-09 (day precision). PeptideScanner associated the retained record with the identity slug metreleptin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-41080980-2025-10-15-853ee76241eb"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-41080980-2025-10-15-853ee76241eb"]}],"sources":[{"id":"pubmed-observation-pmid-41080980-2025-10-15-853ee76241eb","name":"PubMed","sourceClass":"A","title":"Metreleptin In SHORT Syndrome With Uncontrolled Diabetes. · retained source version 1:2025-10-15:current:853ee76241eb30f6e5461ef60bb62a9148edbdea25dd71d3d6cf396f41fe095f","url":"https://pubmed.ncbi.nlm.nih.gov/41080980/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"f9ae5f1fb09e9bc930391b64faa02429bd453ebb87118981a5dbd6a8bad3769a","tierARecordSha256":"33b2a7561e90a3d97640fb2d401f1661a1e913dfee195aa59c1bc7f882db6794"},"integrity":{"algorithm":"sha256","contentSha256":"29e4628318ca4aacefaceeae64af40e685366dfdd6c9531c8e4ab730abfc7fb7"}},"pubmed-pmid-42222073-metreleptin-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-42222073-metreleptin:v1","objectPathId":"pubmed-pmid-42222073-metreleptin-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-42222073-metreleptin/","json":"https://peptidescanner.com/evidence/v1/peptides/metreleptin.json#pubmed-pmid-42222073-metreleptin-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/metreleptin.md#pubmed-pmid-42222073-metreleptin-v1"},"story":{"slug":"pubmed-pmid-42222073-metreleptin","version":1,"domain":"Literature metadata","dateInSource":"2026-08-13","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["metreleptin"],"peptides":[{"slug":"metreleptin","url":"https://peptidescanner.com/peptides/metreleptin/"}]},"claims":[{"id":"headline","text":"Case Report: Twenty years of metreleptin therapy in congenital generalized lipodystrophy type 1: the longest reported follow-up to date.","sourceIds":["pubmed-observation-pmid-42222073-2026-08-13-289aa023c008"]},{"id":"summary","text":"PubMed lists PMID 42222073 in Frontiers in endocrinology as Case Reports, Journal Article, with publication-date metadata of 2026-05-13 (day precision). PeptideScanner associated the retained record with the identity slug metreleptin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-42222073-2026-08-13-289aa023c008"]},{"id":"paragraph-1","text":"PubMed lists PMID 42222073 in Frontiers in endocrinology as Case Reports, Journal Article, with publication-date metadata of 2026-05-13 (day precision). PeptideScanner associated the retained record with the identity slug metreleptin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-42222073-2026-08-13-289aa023c008"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-42222073-2026-08-13-289aa023c008"]}],"sources":[{"id":"pubmed-observation-pmid-42222073-2026-08-13-289aa023c008","name":"PubMed","sourceClass":"A","title":"Case Report: Twenty years of metreleptin therapy in congenital generalized lipodystrophy type 1: the longest reported follow-up to date. · retained source version 1:2026-08-13:current:289aa023c00834affe07cc8eb8d20a123715d63f2eb799abc0bd59f1eb3ca2cf","url":"https://pubmed.ncbi.nlm.nih.gov/42222073/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"103e297707e95e0ca4a77cca9ec5b667091f970b2d33c8fb9456252da607bccc","tierARecordSha256":"47560c7e3ec28642b066ffa732fbe1d74d9dfe69adee45f5aa0c814519f4d16f"},"integrity":{"algorithm":"sha256","contentSha256":"342e446a0a14b64b536c717f7b4d684429be4f2161e5e9f50aaf8323e2a582b5"}}}}
